BEAT
LIVE

Serial Number

79290978

Owner

ICHNOS SCIENCES SA

Attorney

Jeffrey H. Greger

Filing Date

May 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BEAT Trademark

Serial Number: 79290978 • Registration: 6617145

BEAT is a trademark filed by ICHNOS SCIENCES SA on May 29, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ICHNOS SCIENCES SA (9 trademarks)

CHEMIN DE LA COMBETA 5 10166 , CH

Entity Type: 33

Trademark Details

Filing Date

May 29, 2020

Registration Date

January 18, 2022

Published for Opposition

November 2, 2021

Goods & Services

Scientific, weighing, measuring, checking, supervision and teaching apparatus and instruments for scientific laboratory research in the field of antibodies, trimeric antibodies and derivatives thereof, namely, laboratory equipment for purifying, detecting and analysing antibodies, trimeric antibodies and derivatives thereof

Medical preparations, namely, antibodies, trimeric antibodies and derivatives thereof, for the treatment of cancer, allergies, asthma, autoimmune diseases, inflammation, graft versus host diseases, inflammation, transplant rejection, infectious diseases, bone diseases, heart diseases, endocrine diseases, eye diseases, intestinal diseases and neurological diseases, in the form of parenteral, intravitreal, intra-peritoneal and aerosol therapies; medical preparations, namely, antibodies for diagnostic or therapeutic use and for use in assays

Developing promotional campaigns for patient support programs

Chemical products used in industry and science as well as in agriculture, horticulture and forestry, particularly laboratory chemicals, biochemicals in the nature of antibodies, trimeric antibodies and derivatives thereof, all for use in the development or manufacture of immunological reagents for industrial and scientific use; laboratory chemicals, biochemicals in the nature of antibodies, trimeric antibodies and derivatives thereof for laboratories, diagnostics and analytics for scientific or research use; chemical preparations for industrial and scientific use

Medical services, medical clinics, medical assistance; consulting services in the field of healthcare, oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services in the nature of pharmacy advice; hygienic and beauty care for human beings or animals; veterinary services; agriculture, horticulture and forestry services, namely, compost spreading; providing information in the field of medicine and health

Medical apparatus and instruments in the nature of medical devices and instruments to purify, detect and analyse antibodies, trimeric antibodies and derivatives thereof from patient samples who have a respiratory conditions; spirometers; medical devices in the nature of medical devices and instruments to purify, detect and analyse antibodies, trimeric antibodies and derivatives thereof from patient samples from body fluid samples; means of administration of medicinal products such as inhalers and nasal spray nebulizers; Medical apparatus and instruments in the nature of syringes for medical purposes; medical devices and instruments to purify, detect and analyse antibodies , trimeric antibodies and derivatives thereof from patient blood samples; diagnostic apparatus for medical use for detection of cancer

Medical research, namely, laboratory research in the field of antibodies, trimeric antibodies and derivatives thereof; product development in the field of medicines, namely, antibodies, trimeric antibodies and derivatives thereof; product development in the field of diagnostic and testing apparatus and instruments for the identification of diseases, namely, antibodies, trimeric antibodies and derivatives thereof; industrial research in the field of antibodies, trimeric antibodies and derivatives thereof; analysis of antibodies, trimeric antibodies and derivatives thereof in the nature of industrial analysis; contract research services in the field of antibodies, trimeric antibodies and derivatives thereof

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 28, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 29, 2022 OPNX
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 12, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 12, 2022 OPNR
NOTIFICATION PROCESSED BY IB
Nov 8, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 13, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 13, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2020 NREP
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 6, 2020 REPR